Top Markets
Coin of the day
AlzeCure Pharma AB AlzeCure Pharma AB

AlzeCure Pharma AB

ALZCUR
Rang in aandelen #22112
AlzeCure Pharma AB (publ) operates as a pharmaceutical company that develops... AlzeCure Pharma AB (publ) operates as a pharmaceutical company that develops drug therapies for the treatment of severe diseases and conditions that affect the central nervous system. The company is involved in the development of drug candidates based on the NeuroRestore, Alzstatin, and Painless research platforms. Its products pipeline includes ACD856 for the treatment of Alzheimer’s disease, sleep disorders, depression, traumatic brain injuries, and Parkinson’s disease, which is in phase I clinical trial; ACD857, ACD679, and ACD680 that are in preclinical trial for the treatment of Alzheimer’s disease; ACD440, a TRPV1 antagonist that has completed phase I clinical trial for neuropathic pain indications; and ACD137, negative allosteric modulator (NAM) of TrkA receptors for osteoarthritic pain indications. The company was founded in 2012 and is based in Huddinge, Sweden.
Aandeelprijs
$0.71707249
Laatst gesynchroniseerd: 2026-08-21
Marktkapitalisatie
$94.14M
Verandering (1 dag)
-3.31%
Verandering (1 jaar)
76.82%
Land
SE
Handel AlzeCure Pharma AB (ALZCUR)

Categorie

Koersgeschiedenis voor AlzeCure Pharma AB (ALZCUR)
Hoogste slotkoers: $0.75 op 2026-08-01

Laagste slotkoers: $1.08 op 2018-11-01
Koersgeschiedenis van AlzeCure Pharma AB van 2018 tot 2026
Jaarlijkse koersprestatie
Jaar Prestaties
2026 (TTM) 27.37%
2025 118.89%
2024 -63.25%
2023 -21.67%
2022 -38.07%
2021 -40.60%
2020 149.60%
2019 -53.66%
2018 0.00%
Aandelenkoers van vergelijkbare bedrijven of concurrenten
Bedrijf Aandelenkoers Verandering 1jr% Land
$547.71 38.62%
US
$1.04K 58.06%
NL
$145.75 437.43%
US
$118.70 -15.60%
AU
$770.19 8.98%
CH